Spiral Genetics Genome In a Bottle Consortium Releases Structural Variant Calling Benchmark Data Premium The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods. Omicia Acquires Variant Analysis Software Firm Spiral Genetics In addition to variant detection technology, Omicia also gets technologies like data compression, which will aid diagnostics development and data storage. Spiral Genetics, Curoverse Ink Cloud Partnerships With Microsoft Premium Both companies have made their products available on Azure, and Curoverse is collaborating with Microsoft on benchmarking tools for analysis pipelines. Spiral Genetics Launches Large-Scale Query Tech, Kicks Off Pilot With Baylor College of Medicine Premium Spiral has developed graph-based query technology for compressing and querying large genomic cohorts quickly that is currently being piloted at Baylor College of Medicine JGI, Stanford Tap Spiral's Software for Energy Research, Variant Detection DOE's JGI and Stanford will use Spiral's variant detection solutions in sustainable energy research and disease studies. Nov 7, 2014 Spiral Genetics Refocuses Business on Productizing New Structural Variant Detection Methodology Premium Feb 7, 2014 Venture Capitalists Weigh in on What Recent Bioinformatics Investments Mean for the Market Premium Mar 15, 2013 Spiral Raises $3M in Financing, Pursues Partnerships to Tap into Clinical Genomics Analysis Market Premium Mar 12, 2013 Spiral Genetics Completes $3M Series A Round, Partners with Omicia Jan 4, 2013 New Players, Clinical Applications, and the Lure of Commercialization among 2012 Bioinformatics Trends Premium Aug 24, 2012 Software Vendors Cautiously Optimistic as Illumina Readies BaseSpace App Store for Market Premium Breaking News Sequencing Study Uncovers MERS-Related Coronavirus in Swiss Bats Angstrom Bio Raises $3M in Private Financing Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test Centogene Q1 Revenues Grow More Than Fivefold Driven by COVID-19 Testing Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing Enzo Biochem, CLX Health Partner to Support COVID-19 Testing for International Travel The Scan CDC Calls Delta "Variant of Concern" CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern." From FDA to Venture Capital Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post. Consent Questions Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles. Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.